Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Dienogest 2 mg tablets (Naari Pharma) vs Visanne in healthy female volunteers under fasting conditions
TCTR20220906003Phase 1Unknown
- Sponsor
- Abbott Laboratories
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dienogest in endometriosis (2 arms), sponsored by Abbott Laboratories. Status: unknown.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on TCTR20220906003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220906003.